NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical company developing exosome-based regenerative therapies, announced today its ...

For decades, a blood draw in a clinical lab was the only way to quantify your hormones. In 2026, that paradigm is shifting and we are seeing saliva cartridges analyzed by smartphone AI, DNA-based ...

In recent years, mRNA in lipid nanoparticles (mRNA–LNPs) has emerged as a promising strategy for treating numerous conditions ...

Structural nanomedicine — what helped give us the COVID vaccine — may now be the key to a potent blood cancer treatment that’s had remarkable early results.

Protopasta unveiled a quantum dot filament at CES 2026 that glows in intense, vivid colors under UV light. Developed with ...

RNA structural biology has rapidly evolved from interpreting RNA as a passive genetic messenger to positioning it as a key programmable component for ...

When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don ...

When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don't fight them - throw them in the cellular trash.

The Kiel University scientist discusses how advanced materials processing is shaping medical manufacturing and improving drug performance.

GA, UNITED STATES, February 3, 2026 / EINPresswire.com / — Atomically engineered nanozymes ( AENs) combine precise nanotechnology with catalytic functions to enhance immune regulation through ...

Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based ...

In an era of escalating biological threats, from weaponized pathogens to evolving viruses like Mpox, small U.S. biotechs are stepping up to bolster military readiness and national security.